ANAVEX LIFE SCIENCES CORP. Convertible Debt, Noncurrent
ANAVEX LIFE SCIENCES CORP. (AVXL) had Convertible Debt, Noncurrent of $1.09 thousand as of 2014-06-30, per its 10-Q filed 2014-08-13.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt, Excluding Current Maturities
us-gaap:ConvertibleDebtNoncurrent · last filed 2014-08-13
- 2014-06-30: Convertible Debt, Noncurrent $1.09K.
- 2014-03-31: Convertible Debt, Noncurrent $1.01K.
- 2013-09-30: Convertible Debt, Noncurrent $0.00.
| Period end | Convertible Debt, Noncurrent |
|---|---|
| 2014-06-30 | $1.09K 10-Q · filed 2014-08-13 |
| 2014-03-31 | $1.01K 10-Q/A · filed 2014-05-30 |
| 2013-09-30 | $0.00 10-Q · filed 2014-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |